GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » Asset Turnover

Moss Genomics (XCNQ:MOSS) Asset Turnover : 0.00 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Moss Genomics's Revenue for the three months ended in Dec. 2024 was C$0.00 Mil. Moss Genomics's Total Assets for the quarter that ended in Dec. 2024 was C$0.07 Mil. Therefore, Moss Genomics's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Moss Genomics's annualized ROE % for the quarter that ended in Dec. 2024 was 446.15%. It is also linked to ROA % through Du Pont Formula. Moss Genomics's annualized ROA % for the quarter that ended in Dec. 2024 was -341.18%.


Moss Genomics Asset Turnover Historical Data

The historical data trend for Moss Genomics's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics Asset Turnover Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
Asset Turnover
- -

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Moss Genomics's Asset Turnover

For the Health Information Services subindustry, Moss Genomics's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moss Genomics's Asset Turnover Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Moss Genomics's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Moss Genomics's Asset Turnover falls into.


;
;

Moss Genomics Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Moss Genomics's Asset Turnover for the fiscal year that ended in Jun. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jun. 2023 )/( (Total Assets (A: Jun. 2022 )+Total Assets (A: Jun. 2023 ))/ count )
=0/( (0.802+0.127)/ 2 )
=0/0.4645
=0.00

Moss Genomics's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (0.077+0.059)/ 2 )
=0/0.068
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Moss Genomics  (XCNQ:MOSS) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Moss Genomics's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-0.232/-0.052
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.232 / 0)*(0 / 0.068)*(0.068/ -0.052)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-1.3077
=ROA %*Equity Multiplier
=-341.18 %*-1.3077
=446.15 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Moss Genomics's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=-0.232/0.068
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.232 / 0)*(0 / 0.068)
=Net Margin %*Asset Turnover
= %*0
=-341.18 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Moss Genomics Asset Turnover Related Terms

Thank you for viewing the detailed overview of Moss Genomics's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Moss Genomics Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 907, Vancouver, BC, CAN, V6E 2Y3
Moss Genomics Inc is an emerging consumer genomics company that offers personalized health, antiaging and wellness offerings guided by genomic, microbiome, and epigenome data. The Company intends to eliminate barriers in healthcare by offering easy-access, at-home, affordable testing paired with easy-to-understand actionable results.
Executives
Lucas Cahill 10% Security Holder

Moss Genomics Headlines

No Headlines